Cargando…

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis

Mycobacterium tuberculosis infects over 10 million people annually and kills more people each year than any other human pathogen. The current tuberculosis (TB) vaccine is only partially effective in preventing infection, while current TB treatment is problematic in terms of length, complexity and pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Diana H., Nagalingam, Gayathri, Luck, Ian, Proschogo, Nicholas, Pillalamarri, Vijaykumar, Addlagatta, Anthony, Martinez, Elena, Sintchenko, Vitali, Rutledge, Peter J., Triccas, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779907/ https://www.ncbi.nlm.nih.gov/pubmed/31591407 http://dx.doi.org/10.1038/s41598-019-50748-2

Ejemplares similares

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice
por: Counoupas, Claudio, et al.
Publicado: (2016)

Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
por: García-Pinel, Beatriz, et al.
Publicado: (2020)

The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria
por: Porras-Alcalá, Cristina, et al.
Publicado: (2022)

Synergistic Anti-Candida Activity of Bengazole A in the Presence of Bengamide A †
por: Jamison, Matthew T., et al.
Publicado: (2019)

Chemistry and Biology of Bengamides and Bengazoles, Bioactive Natural Products from Jaspis Sponges
por: García-Ruiz, Cristina, et al.
Publicado: (2014)

Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia
por: Gurjav, Ulziijargal, et al.
Publicado: (2014)

Immunity to Mycobacterium tuberculosis
por: Triccas, James A., et al.
Publicado: (2011)

The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects
por: White, Kimberly N., et al.
Publicado: (2017)

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine
por: Armitage, Ellis, et al.
Publicado: (2023)

Analysis of stress- and host cell-induced expression of the Mycobacterium tuberculosis inorganic pyrophosphatase
por: Triccas, James A, et al.
Publicado: (2001)

M. tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of Infection
por: Blumenthal, Antje, et al.
Publicado: (2012)

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021)

Extensive Homoplasy but No Evidence of Convergent Evolution of Repeat Numbers at MIRU Loci in Modern Mycobacterium tuberculosis Lineages
por: Outhred, Alexander C., et al.
Publicado: (2020)

Exploring programmatic indicators of tuberculosis control that incorporate routine Mycobacterium tuberculosis sequencing in low incidence settings: a comprehensive (2017–2021) patient cohort analysis
por: Zhang, Xiaomei, et al.
Publicado: (2023)

In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor
por: Mondal, Rajesh, et al.
Publicado: (2023)

Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis
por: Counoupas, Claudio, et al.
Publicado: (2020)

Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia
por: Gurjav, Ulziijargal, et al.
Publicado: (2016)

The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice
por: Kao, Fan F., et al.
Publicado: (2012)

Migration and descent, adaptations to altitude and tuberculosis in Nepalis and Tibetans
por: Corbett, Stephen, et al.
Publicado: (2022)

Rapid Antibacterial Activity of Cannabichromenic Acid against Methicillin-Resistant Staphylococcus aureus
por: Galletta, Maria, et al.
Publicado: (2020)

Spoligologos: A Bioinformatic Approach to Displaying and Analyzing Mycobacterium tuberculosis Data
por: Driscoll, Jeffrey R., et al.
Publicado: (2002)

Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity
por: Yu, Mingfeng, et al.
Publicado: (2013)

Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of Mycobacterium tuberculosis
por: Bajrai, Leena Hussein, et al.
Publicado: (2022)

Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study
por: Khandkar, Chinmay, et al.
Publicado: (2015)

Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice
por: Karakousis, Petros C., et al.
Publicado: (2004)

Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
por: Foo, Caroline S., et al.
Publicado: (2018)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System
por: Nisa, Annuurun, et al.
Publicado: (2022)

Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity
por: Bekier, Adrian, et al.
Publicado: (2021)

Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis
por: Yu, Xia, et al.
Publicado: (2022)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
por: Muflihah, Heni, et al.
Publicado: (2021)

dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains
por: Moradigaravand, Danesh, et al.
Publicado: (2016)

Novel T7 Phage Display Library Detects Classifiers for Active Mycobacterium Tuberculosis Infection
por: Talwar, Harvinder, et al.
Publicado: (2018)

Informatics for Infectious Disease Research and Control
por: Sintchenko, Vitali
Publicado: (2009)

Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis
por: Hajian, Behnoush, et al.
Publicado: (2016)

Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam
por: Callum, Jack, et al.
Publicado: (2022)

Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation
por: Snášel, Jan, et al.
Publicado: (2021)

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
por: Daniel, Lina, et al.
Publicado: (2022)

Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis
por: Noschka, Reiner, et al.
Publicado: (2021)

Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
por: Chen, Cheng-Cheung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0b9qtfc72bhuk7hes34gf6c24f